SCHEMBL18914564

SCHEMBL18914564

N#Cc1ccc(-c2c3ccccc3c(-c3cc4c(-c5ccccc5)nc5cc6ccccc6cc5c4c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.45
ESR2 Q92731 6/20 0.45
ADORA2A P29274 3/20 0.40
ADORA1 P30542 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
ABCB1 P08183 1/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
ESRRB O95718 1/20 0.35
ESRRA P11474 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
HPGD P15428 1/20 0.35
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037772 0.91 ADORA2A (0.43) ESR1ESR2ADORA2AABCG2ABCB1
SCHEMBL18914782 0.86 ADORA2A (0.36) ESR1ESR2ADORA2AADORA1ABCG2
SCHEMBL18907279 0.86 ADORA2A (0.36) ESR1ESR2ADORA2AADORA1ALDH1A1
SCHEMBL18914565 0.84 ALDH1A1 (0.41) ESR1ESR2ADORA2AADORA1ALDH1A1
SCHEMBL18907270 0.84 ESR1 (0.49) ESR1ESR2ADORA2AADORA1ALDH1A1
SCHEMBL18914557 0.83 PDPK1 (0.38) ADORA2AADORA1ABCG2ABCB1ALDH1A1
SCHEMBL17037315 0.83 ADORA2A (0.41) ADORA2AABCG2ABCB1ALDH1A1KDM4E
SCHEMBL18907303 0.82 ESR1 (0.43) ESR1ESR2ADORA2AABCG2ALDH1A1
SCHEMBL19020501 0.82 ADORA2A (0.37) ADORA2AADORA1ABCG2ABCB1ALDH1A1
SCHEMBL18907252 0.81 ESR1 (0.44) ESR1ESR2ADORA2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 ESR1 114/4885ESR2 456/4885ADORA2A 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.